Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Study Evaluating the Efficacy of Esomeprazole/naproxen BID [twice daily] and Celecoxib QD [once daily] in Patients With Osteoarthritis of the Knee.

Trial Profile

Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Study Evaluating the Efficacy of Esomeprazole/naproxen BID [twice daily] and Celecoxib QD [once daily] in Patients With Osteoarthritis of the Knee.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs Celecoxib; Esomeprazole/naproxen
  • Indications Musculoskeletal pain; NSAID-induced gastrointestinal damage; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors POZEN
  • Most Recent Events

    • 01 Dec 2011 Results published in the Annals of Medicine.
    • 28 Apr 2011 Results published in the Current Medical Research and Opinion.
    • 01 Jan 2009 Actual completion date added, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top